A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.

NCT07523100 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS)

Interventions

DRUG: Universal STAR-T Cell Injection

Sponsor

Daishi Tian

Collaborators

[object Object]